67 related articles for article (PubMed ID: 16697773)
1. Differential gene expression identifies subgroups of renal cell carcinoma.
Skubitz KM; Zimmermann W; Kammerer R; Pambuccian S; Skubitz AP
J Lab Clin Med; 2006 May; 147(5):250-67. PubMed ID: 16697773
[TBL] [Abstract][Full Text] [Related]
2. Genomic differences between black and white patients implicate a distinct immune response to papillary renal cell carcinoma.
Paulucci DJ; Sfakianos JP; Skanderup AJ; Kan K; Tsao CK; Galsky MD; Hakimi AA; Badani KK
Oncotarget; 2017 Jan; 8(3):5196-5205. PubMed ID: 28029648
[TBL] [Abstract][Full Text] [Related]
3. Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array.
Boer JM; Huber WK; Sültmann H; Wilmer F; von Heydebreck A; Haas S; Korn B; Gunawan B; Vente A; Füzesi L; Vingron M; Poustka A
Genome Res; 2001 Nov; 11(11):1861-70. PubMed ID: 11691851
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of Zinc Finger Protein 395 Contributes to the Pathogenesis of Chondrosarcoma.
Chen C; Zhou H; Liu Z; Ma X
Onco Targets Ther; 2021; 14():3545-3553. PubMed ID: 34113121
[TBL] [Abstract][Full Text] [Related]
5. The Role of Artificial Intelligence in the Diagnosis and Prognosis of Renal Cell Tumors.
Giulietti M; Cecati M; Sabanovic B; Scirè A; Cimadamore A; Santoni M; Montironi R; Piva F
Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33573278
[TBL] [Abstract][Full Text] [Related]
6. Combination of mTOR and MAPK Inhibitors-A Potential Way to Treat Renal Cell Carcinoma.
Chauhan A; Semwal DK; Mishra SP; Goyal S; Marathe R; Semwal RB
Med Sci (Basel); 2016 Oct; 4(4):. PubMed ID: 29083380
[TBL] [Abstract][Full Text] [Related]
7. ZNF395 Is an Activator of a Subset of IFN-Stimulated Genes.
Schroeder L; Herwartz C; Jordanovski D; Steger G
Mediators Inflamm; 2017; 2017():1248201. PubMed ID: 28316371
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of fatty acid binding protein 7 and its effect on fatty acid of renal cell carcinoma cell lines.
Takaoka N; Takayama T; Ozono S
BMC Cancer; 2017 Mar; 17(1):192. PubMed ID: 28292269
[TBL] [Abstract][Full Text] [Related]
9. Gene expression identifies heterogeneity of metastatic behavior among gastrointestinal stromal tumors.
Skubitz KM; Geschwind K; Xu WW; Koopmeiners JS; Skubitz AP
J Transl Med; 2016 Feb; 14():51. PubMed ID: 26873324
[TBL] [Abstract][Full Text] [Related]
10. The Transcription Factor ZNF395 Is Required for the Maximal Hypoxic Induction of Proinflammatory Cytokines in U87-MG Cells.
Herwartz C; Castillo-Juárez P; Schröder L; Barron BL; Steger G
Mediators Inflamm; 2015; 2015():804264. PubMed ID: 26229239
[TBL] [Abstract][Full Text] [Related]
11. Classification models for clear cell renal carcinoma stage progression, based on tumor RNAseq expression trained supervised machine learning algorithms.
Jagga Z; Gupta D
BMC Proc; 2014; 8(Suppl 6 Proceedings of the Great Lakes Bioinformatics Confer):S2. PubMed ID: 25374611
[TBL] [Abstract][Full Text] [Related]
12. Gene expression identifies heterogeneity of metastatic behavior among high-grade non-translocation associated soft tissue sarcomas.
Skubitz KM; Skubitz AP; Xu WW; Luo X; Lagarde P; Coindre JM; Chibon F
J Transl Med; 2014 Jun; 12():176. PubMed ID: 24950699
[TBL] [Abstract][Full Text] [Related]
13. The hypoxia-inducible transcription factor ZNF395 is controlled by IĸB kinase-signaling and activates genes involved in the innate immune response and cancer.
Jordanovski D; Herwartz C; Pawlowski A; Taute S; Frommolt P; Steger G
PLoS One; 2013; 8(9):e74911. PubMed ID: 24086395
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma deep sequencing: recent developments.
Farber LJ; Furge K; Teh BT
Curr Oncol Rep; 2012 Jun; 14(3):240-8. PubMed ID: 22535504
[TBL] [Abstract][Full Text] [Related]
15. Basic research in kidney cancer.
Oosterwijk E; Rathmell WK; Junker K; Brannon AR; Pouliot F; Finley DS; Mulders PF; Kirkali Z; Uemura H; Belldegrun A
Eur Urol; 2011 Oct; 60(4):622-33. PubMed ID: 21741760
[TBL] [Abstract][Full Text] [Related]
16. Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns.
Brannon AR; Reddy A; Seiler M; Arreola A; Moore DT; Pruthi RS; Wallen EM; Nielsen ME; Liu H; Nathanson KL; Ljungberg B; Zhao H; Brooks JD; Ganesan S; Bhanot G; Rathmell WK
Genes Cancer; 2010 Feb; 1(2):152-163. PubMed ID: 20871783
[TBL] [Abstract][Full Text] [Related]
17. Gene expression programs of mouse endothelial cells in kidney development and disease.
Brunskill EW; Potter SS
PLoS One; 2010 Aug; 5(8):e12034. PubMed ID: 20706631
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma: where will the state-of-the-art lead us?
Brannon AR; Rathmell WK
Curr Oncol Rep; 2010 May; 12(3):193-201. PubMed ID: 20425079
[TBL] [Abstract][Full Text] [Related]
19. Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment.
Phan JH; Moffitt RA; Stokes TH; Liu J; Young AN; Nie S; Wang MD
Trends Biotechnol; 2009 Jun; 27(6):350-8. PubMed ID: 19409634
[TBL] [Abstract][Full Text] [Related]
20. From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma.
Arsanious A; Bjarnason GA; Yousef GM
Mol Cancer; 2009 Mar; 8():20. PubMed ID: 19291329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
